talipexole domnin dopamine agonist marketed treatment parkinsons disease japan boehringer ingelheim introduced december approved marketing us talipexole dopamine receptor agonist interacts pre postsynaptic receptors also main side effects drowsiness dizziness hallucinations minor gastrointestinal japan ministry health labour welfare mandated boehringer add warning label concerning risk sudden onset nalkylation allyl bromide presence potassium carbonate gives halogenated molecular bromine acetic acid give last step involves cyclization thiourea refluxing ethanol completing synthesis talipexole drug article relating nervous system stub help wikipedia expanding ithttpsenwikipediaorgwikitalipexole